Press Release: European Medicines Agency recommends restricting the use of dexrazoxane-containing medicines

Author (Corporate)
Series Title
Series Details EMA/491205/2011 (24.6.11)
Publication Date 24/06/2011
Content Type

The European Medicines Agency (EMA), in June 2011, recommended restricting the use of dexrazoxane to adult patients with advanced or metastatic breast cancer who have already received a certain amount of the anthracyclines doxorubicin and epirubicin to treat their cancer. The Agency’s Committee for Medicinal Products for Human Use (CHMP) also recommended contraindicating the use of this medicine in children.
Source Link http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/06/news_detail_001288.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Press Release: EMA/491205/2011 (24.6.11) http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2011/06/WC500108013.pdf
Subject Categories
Countries / Regions